Skip to main content
OpenTrials

Clinical trial condition

Synucleinopathies

Explore clinical trials studying Synucleinopathies. Study availability and eligibility vary by location and protocol.

33 public trials 16 recruiting studies
Refine in advanced search Browse all conditions

Synucleinopathies trial results

Recruiting

A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

NCT07589595

Conditions
Alzheimer Disease, Amyloid, Basal Ganglia Diseases, +17 more
Locations
  • TrialSphere Corp Chandler, Arizona, United States
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • Profound Research LLC Carlsbad, California, United States
  • Irvine Clinical Research Irvine, California, United States
View all 72 locations
View Trial Details
Recruiting

Alpha-Synuclein PET/CT in Various α-Syn-Related Disease

NCT06949670

Conditions
Alpha Synuclein Pathology, Alpha-Synuclein, Basal Ganglia Diseases, +12 more
Locations
  • The First Affiliated Hospital of University of Science and Technology of China Hefei, Anhui, China
  • Tianjin Medical University General Hospital Tianjin, Tianjin Municipality, China
  • The Affiliated Hospital of Qingdao University Qingdao, Shandong, China
View Trial Details
Recruiting

An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)

NCT06996652

Conditions
Mental Disorders, Metabolic Diseases, Nervous System Diseases, +8 more
Locations
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • University of Colorado Anschutz Aurora, Colorado, United States
  • Yale Medicine North Haven, Connecticut, United States
  • Parkinson's Disease & Movement Disorders Center of Boca Raton Boca Raton, Florida, United States
View all 19 locations
View Trial Details

Related conditions